TP53 and hepatocellular carcinoma: Indeed, a recent study reported the use of qPCR-based analysis of TP53 c.747G>T (p.R249S) and aberrant methylation of the GSTP1 and RASSF1A genes in the urine of 10 HCC patients to monitor recurrence during follow-up (77).